Skip to main content
. 2022 Dec 13;11(1):e03872-22. doi: 10.1128/spectrum.03872-22

TABLE 1.

Significance analysis of the titer differences of recombinant PEDVs at different time pointsa

Strain Mean titer (log10 TCID50/mL) at hpi
12 24 36 48 60 72 84
With trypsin
 r-Satt 1.83 C 1.58 C 2.16 B 2.08 C 2.25 C 3.17 B 3.33 B
 r-Spar(530–936 aa)att 2.75 AB 2.92 AB 3.67 A 3.75 B 3.75 B 5.00 A 4.42 A
 r-SparAEatt 2.00 BC 2.58 B 3.50 A 4.17 AB 4.50 A 4.83 A 4.50 A
 r-Spar(605, 633, 891)att 3.25 A 3.42 A 3.25 A 4.33 A 4.67 A 4.5 A 4.42 A
Without trypsin
 r-Satt 3.67 A 4.67 A 5.83 A 6.25 A 6.75 A 6.92 A 6.25 A
 r-Spar(530–936 aa)att 2.42 B 2.92 B 3.58 B 4.00 B 4.33 B 4.50 B 5.00 B
 r-SparAEatt 2.17 B 2.25 C 3.17 B 3.33 BC 3.50 C 3.75 C 3.92 C
 r-Spar(605, 633, 891)att 2.00 B 2.42 BC 2.92 B 2.92 C 3.00 C 3.42 C 3.83 C
a

Titers are expressed as the mean values (log10 TCID50 per milliliter) from three parallel tests. Values marked with the same letter (A, B, or C) are not significantly different (P > 0.05); otherwise, the difference is significant (P < 0.05).